Stanford University researchers have created an antisense oligonucleotide (ASO) therapy to correct a splicing error that causes Timothy syndrome, a severe neurodevelopmental disorder. The ASO therapy has effectively restored cellular defects in lab models, and when tested in an in vivo model using rat brains, it delivered a robust downregulation of aberrant brain activity. This research could be a game-changer for treatment of neurodevelopmental disorders.
Ontario Divisional Court Rules Forensic Reports as Non-Privileged
Hello folks! I was having a peruse around the cyber world when I spotted an interesting conversation on Infosec Exchange – a spot of legal
